RNA therapeutics face key delivery challenges including instability, targeting limits, and scale-up variability. Advances in lipid nanoparticles, micelles, and integrated...

Tumor-associated macrophages (TAMs) are emerging as one of the most critical players in breast cancer progression, and recent studies highlight...

 In the past decade, macrophages have evolved from being seen as simple immune sentinels to multifaceted regulators of inflammation, tissue...

Over the past decade, CRISPR has reshaped how researchers think about viral vector engineering. The shift isn't just about speed—though...

The rapid evolution of gene therapy has pushed functional genomics to the forefront of biomedical innovation. As researchers race to...

Flow cytometry has long been celebrated for its ability to turn complex cellular systems into quantifiable, high‑resolution data. But as...

The transition from bulk "macro-scale" processing to precision "micro-scale" manipulation has fundamentally altered the trajectory of modern biotechnology. At the...

Advanced liposome strategies, including PG anionic formulations and microfluidic manufacturing, are driving a paradigm shift in pharmaceutical development by resolving...

In the race to bring new therapies to patients, one challenge consistently stands out: drug delivery. Discovering powerful molecules is...

Glycobiology, the study of carbohydrates and their interactions in biological systems, has gained considerable attention from researchers and scientists in...